Celero Systems is a life sciences company that develops an ingestible system to detect and reverse opioid overdose.
Celero Systems's investors include PharmStars.
Celero Systems is headquartered in Lincoln, United States.
Celero Systems is a life sciences company that develops an ingestible system to detect and reverse opioid overdose.
Celero Systems is at the Non-equity Assistance stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Celero Systems — Funding & Investors." VCBacked, December 8, 2022, https://www.vcbacked.co/company/celero-systems. Accessed August 15, 2026.
VCBacked. (2022). Celero Systems — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/celero-systems
{{cite web |title=Celero Systems — Funding & Investors |url=https://www.vcbacked.co/company/celero-systems |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated